Alterity Therapeutics Limited Stock
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
09:53:53 25/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4150 AUD | -2.35% |
|
-7.78% | +3.75% |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
| 08-31 | Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options | MT |
| Market Cap | 64.32M 56.44M 53.31M 48.58M 90.94M 6.17B 91.59M 638M 247M 3.15B 242M 236M 10.12B | P/E 2027 * |
-3.04x | P/E 2028 * | -0.38x |
|---|---|---|---|---|---|
| Enterprise Value | 23.42M 20.55M 19.41M 17.69M 33.11M 2.24B 33.35M 232M 89.97M 1.15B 87.94M 86.04M 3.69B | EV / Sales 2027 * |
49.3x | EV / Sales 2028 * | 13.7x |
| Free-Float |
97.02% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ATH | Delayed | |
OTC Markets
| PRNAF | Delayed | |
|
Deutsche Boerse AG
| PBN | Delayed | |
|
Börse Stuttgart
| PBN | Delayed |
Last Transcript: Alterity Therapeutics Limited
| 1 day | -2.35% | ||
| 1 week | -7.78% | ||
| Current month | -17.82% | ||
| 1 month | -18.63% | ||
| 3 months | -27.19% | ||
| 6 months | +3.75% | ||
| Current year | +3.75% |
| 1 week | 0.42 |  | 0.44 |
| 1 month | 0.42 | | 0.53 |
| Current year | 0.35 | | 0.78 |
| 1 year | 0.35 | | 0.78 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 1.65 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
| Director of Finance/CFO | - | 30/09/2024 | |
| Chief Tech/Sci/R&D Officer | - | 01/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Exercice | Director | 47,620 | 0.0216% | ||
| 31/08/26 | Buy | Chief Executive Officer | -47,620 | 0.0216% | ||
| 31/08/26 | Buy | Director | 95,240 | 0.0432% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.35% | -7.78% | -24.55% | +27.69% | 64.32M | |
| -0.14% | +4.33% | +9.88% | +31.73% | 47.97B | |
| -1.69% | +1.48% | +53.02% | +33.59% | 44.5B | |
| +2.56% | +7.34% | +382.17% | +594.81% | 43.93B | |
| +0.24% | +2.85% | +9.78% | +89.54% | 41.03B | |
| -0.62% | -1.11% | +4.70% | +46.02% | 29.85B | |
| -0.28% | +1.07% | +26.83% | +152.91% | 17.27B | |
| -0.46% | +1.20% | +26.78% | +41.32% | 15.3B | |
| -2.21% | -4.70% | - | - | 14.82B | |
| +3.37% | +9.21% | +9.93% | - | 15.34B | |
| Average | -0.16% | +1.34% | +55.39% | +127.20% | 27.01B | |
| Weighted average by Cap. | +0.11% | +2.86% | +83.01% | +156.18% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 475K 417K 394K 359K 672K 45.57M 677K 4.71M 1.83M 23.28M 1.79M 1.75M 74.82M | 1.98M 1.74M 1.64M 1.49M 2.8M 190M 2.82M 19.62M 7.6M 96.87M 7.43M 7.27M 311M |
| Net income | -27.54M -24.17M -22.82M -20.8M -38.94M -2.64B -39.21M -273M -106M -1.35B -103M -101M -4.33B | -30.84M -27.07M -25.56M -23.3M -43.61M -2.96B -43.92M -306M -118M -1.51B -116M -113M -4.85B |
| Net Debt | -40.9M -35.89M -33.9M -30.89M -57.83M -3.92B -58.24M -406M -157M -2B -154M -150M -6.44B | -37.15M -32.6M -30.79M -28.06M -52.53M -3.56B -52.9M -368M -143M -1.82B -139M -136M -5.85B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | A$0.4150 | -2.35% | 115,271 |
| 24/09/26 | A$0.4250 | -1.16% | 41,962 |
| 23/09/26 | A$0.4300 | +2.38% | 123,420 |
| 22/09/26 | A$0.4200 | -2.33% | 84,743 |
| 21/09/26 | A$0.4300 | -4.44% | 25,847 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
